Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays
- 1 November 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 17 (6) , 761-767
- https://doi.org/10.1097/01.bor.0000179943.27777.b1
Abstract
Recent family, twin, and genetic association studies suggest a genetic basis for the susceptibility to systemic sclerosis or scleroderma. The purpose of this review is to summarize the results of genetic association and gene expression profiling studies from January 2004 to May 2005. In the review period, only a handful reports on single nucleotide polymorphism analysis of candidate genes and transcriptional profiling have been published. Currently, single nucleotide polymorphism association studies in systemic sclerosis use small sample sizes and have low reproducibility. To detect associations with candidate genes that confer a modest relative risk for disease in the general population, studies are needed with much larger sample sizes that also account for the effects of population stratification. Candidate genes or pathways identified through microarrays can be explored as potential biomarkers, used for molecular phenotyping of systemic sclerosis, or targeted for future genetic association studies.Keywords
This publication has 43 references indexed in Scilit:
- Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early diseaseArthritis & Rheumatism, 2005
- Genetic Inheritance of Gene Expression in Human Cell LinesAmerican Journal of Human Genetics, 2004
- Genomic Control to the extremeNature Genetics, 2004
- Association of killer cell immunoglobulin‐like receptors with sclerodermaArthritis & Rheumatism, 2004
- Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodiesArthritis & Rheumatism, 2003
- Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to sclerodermaArthritis & Rheumatism, 2002
- Chemokine expression by systemic sclerosis fibroblasts: Abnormal regulation of monocyte chemoattractant protein 1 expressionArthritis & Rheumatism, 2001
- The CD19–CD21 Complex Regulates Signal Transduction Thresholds Governing Humoral Immunity and AutoimmunityImmunity, 1997
- HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodiesHuman Immunology, 1995
- Connective tissue metabolism including cytokines in sclerodermaCurrent Opinion in Rheumatology, 1991